GTBP
GT Biopharma·NASDAQ
--
--(--)
--
--(--)
3.76 / 10
Netural
GT Biopharma's fundamental score is 3.76/10, reflecting a netural stance. Key positives include a healthy interest coverage ratio (15.48) and strong revenue growth (Total operating revenue YoY +78.47%, Operating revenue YoY +92.66%). However, weaknesses such as high Days sales outstanding (72.55) and negative Revenue-MV (-0.26) temper the outlook. The weighted factor model underscores the need to address asset and receivables efficiency to elevate the fundamental grade.
Analysis Checks(8/10)
Revenue-MV
Value-0.26
Score3/3
Weight20.47%
1M Return10.54%
Value-0.26
Score3/3
Weight20.47%
1M Return10.54%
Days sales outstanding
Value72.55
Score1/3
Weight-2.25%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.25%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight16.34%
1M Return8.45%
Value-0.17
Score2/3
Weight16.34%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.63%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.63%
1M Return-1.11%
Asset-MV
Value-0.50
Score1/3
Weight11.94%
1M Return6.68%
Value-0.50
Score1/3
Weight11.94%
1M Return6.68%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.75%
1M Return1.11%
Value78.47
Score2/3
Weight1.75%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight16.32%
1M Return8.45%
Value0.46
Score2/3
Weight16.32%
1M Return8.45%
PB-ROE
Value-0.71
Score2/3
Weight20.35%
1M Return9.14%
Value-0.71
Score2/3
Weight20.35%
1M Return9.14%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.67%
1M Return0.43%
Value92.66
Score2/3
Weight0.67%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight16.04%
1M Return8.41%
Value-0.07
Score2/3
Weight16.04%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight20.47%
1M Return10.54%
Value-0.26
Score3/3
Weight20.47%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.75%
1M Return1.11%
Value78.47
Score2/3
Weight1.75%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-2.25%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.25%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight16.32%
1M Return8.45%
Value0.46
Score2/3
Weight16.32%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight16.34%
1M Return8.45%
Value-0.17
Score2/3
Weight16.34%
1M Return8.45%
PB-ROE
Value-0.71
Score2/3
Weight20.35%
1M Return9.14%
Value-0.71
Score2/3
Weight20.35%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.63%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.63%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.67%
1M Return0.43%
Value92.66
Score2/3
Weight0.67%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight11.94%
1M Return6.68%
Value-0.50
Score1/3
Weight11.94%
1M Return6.68%
Cash-MV
Value-0.07
Score2/3
Weight16.04%
1M Return8.41%
Value-0.07
Score2/3
Weight16.04%
1M Return8.41%
Is GTBP undervalued or overvalued?
- GTBP scores 3.76/10 on fundamentals and holds a Fair valuation at present. Backed by its -834.89% ROE, 0.00% net margin, -1.52 P/E ratio, 4.79 P/B ratio, and 53.02% earnings growth, these metrics solidify its Netural investment rating.
